Literature DB >> 879761

Nafcillin entry into human cerebrospinal fluid.

B E Fossieck, J G Kane, C R Diaz, R H Parker.   

Abstract

The entry of nafcillin into the cerebrospinal fluid (CSF) of humans was studied in the absence of meningeal inflammation. Twenty studies were performed in 18 patients receiving 40 mg of sodium nafcillin per kg intravenously over 30 min. The CSF specimens were obtained at 1, 2, 3, and 4 h postinfusion, and sera were obtained at 5 min and 1, 2, 3, and 4 h. Nafcillin was uniformly detected in the lumbar CSF at 1 h, peaked at 2 h postinfusion, and was still detectable in the CSF of three of four patients studied at 4 h.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 879761      PMCID: PMC352111          DOI: 10.1128/AAC.11.6.965

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  2 in total

1.  Susceptibility of Staphylococcus aureus and Staphylococcus epidermidis to 65 antibiotics.

Authors:  L D Sabath; C Garner; C Wilcox; M Finland
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

2.  Nafcillin treatment of Staphylococcus aureus meningitis.

Authors:  D E Ruiz; J F Warner
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

  2 in total
  4 in total

1.  New rapid assay for nafcillin in serum by spectrofluorometry.

Authors:  D M Lichtenwalner; B Suh; B Lorber; A M Sugar
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

2.  Penetrance of nafcillin into human ventricular fluid: correlation with ventricular pleocytosis and glucose levels.

Authors:  R Yogev; W E Schultz; S B Rosenman
Journal:  Antimicrob Agents Chemother       Date:  1981-04       Impact factor: 5.191

3.  Flucloxacillin treatment of Staphylococcus aureus meningitis.

Authors:  S R Ritchie; P Rupali; S A Roberts; M G Thomas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-07       Impact factor: 5.103

4.  Pharmacokinetic Evaluation of Cefazolin in the Cerebrospinal Fluid of Critically Ill Patients.

Authors:  Alison R Novak; Martin Krsak; Tyree H Kiser; Robert T Neumann; Luis Cava Prado; Kyle C Molina; Scott W Mueller
Journal:  Open Forum Infect Dis       Date:  2021-12-25       Impact factor: 3.835

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.